Melisa J. Willby

1.1k total citations
28 papers, 786 citations indexed

About

Melisa J. Willby is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Melisa J. Willby has authored 28 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 16 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Melisa J. Willby's work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (8 papers) and Cancer therapeutics and mechanisms (8 papers). Melisa J. Willby is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (8 papers) and Cancer therapeutics and mechanisms (8 papers). Melisa J. Willby collaborates with scholars based in United States, Sweden and Switzerland. Melisa J. Willby's co-authors include James E. Posey, Oleg V. Tsodikov, Duncan C. Krause, Seidu Malik, Sylvie Garneau‐Tsodikova, Keith Green, David Sikes, Tae‐Wook Hahn, Atefeh Garzan and Caixia Hou and has published in prestigious journals such as PLoS ONE, Biochemistry and Scientific Reports.

In The Last Decade

Melisa J. Willby

26 papers receiving 779 citations

Peers

Melisa J. Willby
Keira A. Cohen United States
Xia Yu China
Anita G. Amin United States
Steve Fuller United States
Gerjo J. de Knegt Netherlands
Keira A. Cohen United States
Melisa J. Willby
Citations per year, relative to Melisa J. Willby Melisa J. Willby (= 1×) peers Keira A. Cohen

Countries citing papers authored by Melisa J. Willby

Since Specialization
Citations

This map shows the geographic impact of Melisa J. Willby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melisa J. Willby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melisa J. Willby more than expected).

Fields of papers citing papers by Melisa J. Willby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melisa J. Willby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melisa J. Willby. The network helps show where Melisa J. Willby may publish in the future.

Co-authorship network of co-authors of Melisa J. Willby

This figure shows the co-authorship network connecting the top 25 collaborators of Melisa J. Willby. A scholar is included among the top collaborators of Melisa J. Willby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melisa J. Willby. Melisa J. Willby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Sooji, Chris Edens, Troy Ritter, et al.. (2024). Two Outbreaks of Legionnaires Disease Associated with Outdoor Hot Tubs for Private Use — Two Cruise Ships, November 2022–July 2024. MMWR Morbidity and Mortality Weekly Report. 73(42). 950–954. 1 indexed citations
2.
Kozak‐Muiznieks, Natalia A., Jeffrey W. Mercante, Lavanya Rishishwar, et al.. (2024). Expanded geographic distribution for two Legionella pneumophila sequence types of clinical concern. mSphere. 9(11). e0075623–e0075623.
3.
Mohamed, Hani, Abdoulaye Diédhiou, Nakia Clemmons, et al.. (2024). Cluster of Legionellosis Cases Associated with Manufacturing Process, South Carolina, USA, 2022. Emerging infectious diseases. 31(1). 41–49.
4.
Pang, Allan H., Keith Green, Nishad Thamban Chandrika, et al.. (2022). Discovery of substituted benzyloxy-benzylamine inhibitors of acetyltransferase Eis and their anti-mycobacterial activity. European Journal of Medicinal Chemistry. 242. 114698–114698. 11 indexed citations
5.
Willby, Melisa J., Darrin Lemmer, Katherine A. Klein, et al.. (2020). Molecular Evaluation of Fluoroquinolone Resistance in Serial Mycobacterium tuberculosis Isolates from Individuals Diagnosed with Multidrug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 65(1). 1 indexed citations
6.
Ngo, Huy, Keith Green, Melisa J. Willby, et al.. (2020). Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis from Mycobacterium tuberculosis. ACS Chemical Biology. 15(6). 1581–1594. 18 indexed citations
7.
Click, Eleanor S., Wilfred Murithi, Kimberly D. McCarthy, et al.. (2018). Detection of Apparent Cell-free M. tuberculosis DNA from Plasma. Scientific Reports. 8(1). 645–645. 21 indexed citations
8.
Green, Keith, Tapan Biswas, Allan H. Pang, et al.. (2018). Acetylation by Eis and Deacetylation by Rv1151c of Mycobacterium tuberculosis HupB: Biochemical and Structural Insight. Biochemistry. 57(5). 781–790. 27 indexed citations
9.
Homaira, Nusrat, Stephen P. Luby, Kamal Hossain, et al.. (2016). Respiratory Viruses Associated Hospitalization among Children Aged <5 Years in Bangladesh: 2010-2014. PLoS ONE. 11(2). e0147982–e0147982. 22 indexed citations
10.
Garzan, Atefeh, Melisa J. Willby, Keith Green, et al.. (2016). Discovery and Optimization of Two Eis Inhibitor Families as Kanamycin Adjuvants against Drug-Resistant M. tuberculosis. ACS Medicinal Chemistry Letters. 7(12). 1219–1221. 29 indexed citations
11.
Willby, Melisa J., et al.. (2015). Correlation between GyrA Substitutions and Ofloxacin, Levofloxacin, and Moxifloxacin Cross-Resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 59(9). 5427–5434. 39 indexed citations
12.
Willby, Melisa J., et al.. (2015). Multiorgan WU Polyomavirus Infection in Bone Marrow Transplant Recipient. Emerging infectious diseases. 22(1). 24–31. 18 indexed citations
13.
Whitfield, Michael G., Robin M. Warren, Elizabeth M. Streicher, et al.. (2015). Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT. Journal of Clinical Microbiology. 53(11). 3633–3635. 26 indexed citations
14.
Reeves, Analise Z., Patricia Campbell, Melisa J. Willby, & James E. Posey. (2014). Disparities in Capreomycin Resistance Levels Associated with the rrs A1401G Mutation in Clinical Isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 59(1). 444–449. 22 indexed citations
15.
Willby, Melisa J., Keith Green, Micha Fridman, et al.. (2014). Antimycobacterial activity of DNA intercalator inhibitors of Mycobacterium tuberculosis primase DnaG. The Journal of Antibiotics. 68(3). 153–157. 34 indexed citations
16.
Malik, Seidu, Melisa J. Willby, David Sikes, Oleg V. Tsodikov, & James E. Posey. (2012). New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations. PLoS ONE. 7(6). e39754–e39754. 131 indexed citations
17.
Prill, Mila M., Marika K. Iwane, Kathryn M. Edwards, et al.. (2011). Human Coronavirus in Young Children Hospitalized for Acute Respiratory Illness and Asymptomatic Controls. The Pediatric Infectious Disease Journal. 31(3). 235–240. 73 indexed citations
18.
Willby, Melisa J. & Duncan C. Krause. (2002). Characterization of a Mycoplasma pneumoniae hmw3 Mutant: Implications for Attachment Organelle Assembly. Journal of Bacteriology. 184(11). 3061–3068. 26 indexed citations
19.
Jordan, Jarrat, et al.. (1999). Mycoplasma pneumoniae Protein P30 Is Required for Cytadherence and Associated with Proper Cell Development. Journal of Bacteriology. 181(4). 1079–1087. 65 indexed citations
20.
Hahn, Tae‐Wook, Melisa J. Willby, & Duncan C. Krause. (1998). HMW1 Is Required for Cytadhesin P1 Trafficking to the Attachment Organelle in Mycoplasma pneumoniae. Journal of Bacteriology. 180(5). 1270–1276. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026